These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8153331)

  • 1. Use of iotrolan versus ethiodized poppy-seed oil in hysterosalpingography.
    Lindequist S; Rasmussen F; Larsen C
    Radiology; 1994 May; 191(2):513-7. PubMed ID: 8153331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic quality and complications of hysterosalpingography: oil- versus water-soluble contrast media--a randomized prospective study.
    Lindequist S; Justesen P; Larsen C; Rasmussen F
    Radiology; 1991 Apr; 179(1):69-74. PubMed ID: 1848715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hysterosalpingography using iotrolan--a new contrast medium].
    Jensen HJ; Dons-Jensen H; Kamal KM
    Aktuelle Radiol; 1993 Sep; 3(5):292-4. PubMed ID: 8399416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of hysterosalpingography: oil- versus water-soluble contrast media--a randomized prospective study.
    Rasmussen F; Lindequist S; Larsen C; Justesen P
    Radiology; 1991 Apr; 179(1):75-8. PubMed ID: 1848716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethiodized poppyseed oil versus ioversol for image quality and adverse events in hysterosalpingography: a prospective cohort study.
    Tan Y; Zheng S; Lei W; Wang F; Jiang S; Zeng T; Zhou B; Hong F
    BMC Med Imaging; 2019 Jun; 19(1):50. PubMed ID: 31234782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hysterosalpingography with a new contrast medium.
    Wolf G; Fitzal P
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():190-4. PubMed ID: 2568792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between iotrolan, a non-ionic dimer, and a hyperosmolar contrast medium, Urografin, in hysterosalpingography.
    Brokensha C; Whitehouse G
    Br J Radiol; 1991 Jul; 64(763):587-90. PubMed ID: 1873659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oil or aqueous contrast media for hysterosalpingography: a prospective, randomized, clinical study.
    de Boer AD; Vemer HM; Willemsen WN; Sanders FB
    Eur J Obstet Gynecol Reprod Biol; 1988 May; 28(1):65-8. PubMed ID: 2839382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Iotrolan-300 versus Iopamidol-300 in hysterosalpingography].
    Schulz-Wendtland R; Bauer M; Henne KW
    Aktuelle Radiol; 1991 Sep; 1(5):256-8. PubMed ID: 1751562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic quality in hysterosalpingography. Comparison between iodixanol and iotrolan.
    Lindequist S; Rasmussen F; Madsen HH; Naeser A; Bjartveit K; Kristoffersen DT; Klaveness AJ
    Acta Radiol; 1998 Nov; 39(6):730-3. PubMed ID: 9817052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy rates after hysterosalpingography with oil- and water-soluble contrast media.
    Alper MM; Garner PR; Spence JE; Quarrington AM
    Obstet Gynecol; 1986 Jul; 68(1):6-9. PubMed ID: 3014408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and pharmacokinetics of iotrolan in hysterosalpingography. Retention and irritability compared with Lipiodol.
    Miyamoto Y; Tsujimoto T; Iwai K; Ishida K; Uchimoto R; Miyazawa T; Azuma H
    Invest Radiol; 1995 Sep; 30(9):538-43. PubMed ID: 8537211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility Outcome and Safety of Ethiodized Poppy Seed Oil for Hysterosalpingography in 1,053 Infertile Patients: A Real-World Study.
    Li H; Ren Y; Yan J; Huang M; Zheng B; Luo X; Huang S; Cai S
    Front Med (Lausanne); 2022; 9():804494. PubMed ID: 35492317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential therapeutic effects of contrast materials in hysterosalpingography: a prospective randomized clinical trial. Kaiser Permanente Infertility Work Group.
    Spring DB; Barkan HE; Pruyn SC
    Radiology; 2000 Jan; 214(1):53-7. PubMed ID: 10644101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic granulomata mimicking endometriosis following the administration of oil-based contrast media for hysterosalpingography.
    Grosskinsky CM; Clark RL; Wilson PA; Novotny DB
    Obstet Gynecol; 1994 May; 83(5 Pt 2):890-2. PubMed ID: 8159388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid Dysfunction in Neonates Born to Mothers Who Have Undergone Hysterosalpingography Involving an Oil-Soluble Iodinated Contrast Medium.
    Satoh M; Aso K; Katagiri Y
    Horm Res Paediatr; 2015; 84(6):370-5. PubMed ID: 26402613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hysterosalpingography with oil contrast medium enhances fertility in patients with infertility of unknown etiology.
    Schwabe MG; Shapiro SS; Haning RV
    Fertil Steril; 1983 Nov; 40(5):604-6. PubMed ID: 6313436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oil-soluble contrast during hysterosalpingography in women with proven tubal patency.
    Steiner AZ; Meyer WR; Clark RL; Hartmann KE
    Obstet Gynecol; 2003 Jan; 101(1):109-13. PubMed ID: 12517654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain associated with hysterosalpingography: Ethiodol versus Salpix media.
    Moore DE
    Fertil Steril; 1982 Nov; 38(5):629-31. PubMed ID: 6290276
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of patient reactions and diagnostic quality for hysterosalpingography using ionic and nonionic contrast media.
    Chen MY; Zagoria RJ; Fayez JA; Ott DJ; Van Swearingen FL
    Acad Radiol; 1995 Feb; 2(2):123-7. PubMed ID: 9419535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.